Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07192757 · ClinicalTrials.gov registry record · NA
Improving Speech in Noise Perception for Individuals With Age-related Hearing Loss
A NA study of Presbycusis, sponsored by University of Florida.
- Recruiting
- Registry status
- NA
- Development phase
- 36
- Enrollment target
- 1
- Study location
NCT07192757 is a NA study of Presbycusis that is actively recruiting participants, run by University of Florida. The registered enrollment target is 36 participants. The trial reports 1 study location across 1 state.
The verdict
NCT07192757, a NA study of Presbycusis, is actively recruiting participants, sponsored by University of Florida.
- RECRUITING
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
- 1
- Study location
Study Summary
Hearing loss, especially for speech perception in the presence of noise, may lead older individuals to withdraw from social situations. While hearing aids help amplify sound and are useful in many situations, they can be ineffective in noisy contexts. The proposed pilot study will evaluate taVNS for improving speech in noise perception in adults with age-related hearing loss.
Conditions Studied
Interventions
- DEVICE transcutaneous auricular vagus nerve stimulation
- DEVICE Sham Control
Study Locations (1)
Florida
- UF Health at the University of Florida - Gainesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2025-12-01 |
| Est. Completion | 2026-07-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07192757
The ClinicalTrials.gov registry entry for NCT07192757 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Presbycusis appearing as the primary indexed condition, and to 2 interventions - of which transcutaneous auricular vagus nerve stimulation is the first listed.
NCT07192757 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT07192757 about?
NCT07192757 is a clinical study titled "Improving Speech in Noise Perception for Individuals With Age-related Hearing Loss". Hearing loss, especially for speech perception in the presence of noise, may lead older individuals to withdraw from social situations. While hearing aids help amplify sound and are useful in many situations, they can be ineffective in noisy contexts. The proposed pilot study will evaluate taVNS for...
What is the current status of trial NCT07192757?
This trial is currently recruiting. It is a NA study. The enrollment target is 36 participants. The study started on 2025-12-01. Estimated completion is 2026-07-30.
What conditions does trial NCT07192757 study?
This clinical trial studies the following conditions: Presbycusis.
What interventions are being tested in trial NCT07192757?
The interventions under investigation include: transcutaneous auricular vagus nerve stimulation (DEVICE), Sham Control (DEVICE).
Who is sponsoring clinical trial NCT07192757?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07192757 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Presbycusis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.